[{"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; VITAMIN B COMPLEX Tablet may be potentially mislabeled as    OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,100 mg, NDC 11523726503, Pedigree: W003789, EXP: 6/27/2014;  prednisoLONE, Tablet, 5 mg, NDC 16477050501, Pedigree: W003627, EXP: 6/25/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "VITAMIN B COMPLEX, Tablet has the following codes    Pedigree: W003820, EXP: 6/27/2014;  Pedigree: W003628, EXP: 6/25/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VITAMIN B COMPLEX, Tablet Over The Counter, Distributed by: AidaPak Service, LLC, NDC 43292055540", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-561-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "L5703 Exp 11/30/2013", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Idoxuridine 0.1% Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-742-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091032"], "brand_name": ["IRINOTECAN HYDROCHLORIDE"], "generic_name": ["IRINOTECAN HYDROCHLORIDE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0143-9701", "0143-9702"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["IRINOTECAN HYDROCHLORIDE"], "rxcui": ["1726319", "1726324"], "spl_id": ["204eb37a-642f-4321-9466-414c32a6bbce"], "spl_set_id": ["be716692-6b4f-47b6-83d1-01665861626b"], "package_ndc": ["0143-9702-01", "0143-9701-01"], "is_original_packager": [true], "upc": ["0301439701019"], "unii": ["042LAQ1IIS"]}, "product_type": "Drugs", "event_id": "66447", "recalling_firm": "West-Ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-66447-002", "product_description": "Irinotecan Hydrochloride Injection, 100 mg/5 mL (20 mg/mL), 1 x 5 mL Single Dose Vial per carton, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Schiffgraben 23, 38690 Vienenburg, Germany; Distributed by: West-Ward Pharmaceutical Corp., Eatontown, NJ  07724 USA, NDC 0143-9701-01.", "product_quantity": "9813 vials", "reason_for_recall": "Superpotent Drug: a recent review of the USP revealed that an incorrect calculation was used to determine the amount of irinotecan to use in formulation which will result in an assay higher than the labeled claim.", "recall_initiation_date": "20130923", "center_classification_date": "20131104", "termination_date": "20160405", "report_date": "20131113", "code_info": "Lot #: AC0026, AC0027, Exp 10/14"}, {"country": "United States", "city": "Lake Forest", "address_1": "150 N Field Dr Ste 350", "reason_for_recall": "Subpotent Drug; confirmed results by FDA analysis after customer complaints of discoloration", "address_2": "", "product_quantity": "6,816 bags", "code_info": "Service Code 2K6134;   15342084S, 15342191S, 15342223S, 15342224S, 15342225S, and 15342226S, exp 2/10/2016; 15343025S,   15343026S,   15343129S, and   15343131S, exp 2/11/2016;   15344157S,   15344160S, and   15344209S, exp 2/12/2016;  15345036S,   15345104S,   15345106S, and   15345142S, exp 2/13/2016;  15346015S,   15346016S,   15346017S,   15346018S,   15346019S,  15346020S,  15346022S, and   15346023S, exp 2/14/2016;  15348152S, and  15348197S, exp 2/16/2016  15350046S, and  15350154S, exp 2/18/2016", "center_classification_date": "20160317", "distribution_pattern": "Nationwide", "state": "IL", "product_description": "NORepinephrine Bitartrate, 4 mg (16 mcg/mL) added to 250 mL 0.9% Sodium Chloride Injection USP, in 250 mL Viaflex Bag, Rx only, PharMEDium Services, LLC, Sugar Land, TX NDC 61553-134-61", "report_date": "20160323", "classification": "Class III", "openfda": {}, "recalling_firm": "Pharmedium Services, LLC", "recall_number": "D-0777-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "72973", "termination_date": "20160406", "more_code_info": "", "recall_initiation_date": "20151231", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Fullerton", "address_1": "1941 W Commonwealth Ave", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: All lots of the dietary supplement Slimdia Revolution are being recalled because they contain sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.", "address_2": "Suite B", "product_quantity": "unknown", "code_info": "There are no manufacturing codes associated with the product.", "center_classification_date": "20130215", "distribution_pattern": "Korea", "state": "CA", "product_description": "SLIMDIA Revolution capsules, 30-count capsules per bottle, Yerba Naturals, 19685 Varda Ave., Buena Park, CA.", "report_date": "20130227", "classification": "Class I", "openfda": {}, "recalling_firm": "P & J Trading Co", "recall_number": "D-165-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "63942", "termination_date": "20130325", "recall_initiation_date": "20121219", "postal_code": "92833-3042", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0558-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Back, Muscle & Joint Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955516125, NDC 57955-6161-2", "product_quantity": "4507 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 012317H Exp. 01/20; 021418A Exp. 02/20; 033116F Exp. 03/19; 072216H Exp. 07/19; 102717C Exp. 10/19"}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10029200 Exp. 11/18/2019,    10030347 Exp. 11/24/2019,    10031325 Exp. 12/16/2019,  10030939 Exp. 12/3/2019,    10031865 Exp. 12/24/2019,  10031758 Exp. 12/26/2019,  10031757 Exp. 12/26/2019,  10032275 Exp. 12/30/2019", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.1% 100 mg/100 mL (1 mg/mL) in 0.9% Sodium Chloride Preservative Free 100 mL in 150 mL Bag, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478  NDC 70092-1103-36", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0565-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077686"], "brand_name": ["MATZIM LA"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["52544-691", "52544-692", "52544-693", "52544-694", "52544-695"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830877", "830879", "830882", "830897", "830900", "1091623", "1091629", "1091632", "1091635", "1091638"], "spl_id": ["49c03dc3-4b1c-4615-b039-6d5d37feb398"], "spl_set_id": ["e8c8dd18-9d95-4068-9762-bec1eb1bc25c"], "package_ndc": ["52544-691-30", "52544-691-19", "52544-691-10", "52544-692-30", "52544-692-19", "52544-692-10", "52544-693-30", "52544-693-19", "52544-693-10", "52544-694-30", "52544-694-19", "52544-694-10", "52544-695-30", "52544-695-19", "52544-695-10"], "is_original_packager": [true], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "83730", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 42 wholesalers and 11 retailers who may have further distribute the product throughout the United States, including Hawaii and Puerto Rico.", "recall_number": "D-0131-2020", "product_description": "Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ  NDC 52544-692-30", "product_quantity": "5,849 bottles", "reason_for_recall": "GMP Deviation: lot not intended for commercial distribution.", "recall_initiation_date": "20190906", "center_classification_date": "20191009", "termination_date": "20200519", "report_date": "20191016", "code_info": "Lot # 1344864A, exp. date 10/2020"}, {"country": "United States", "city": "Harriman", "address_1": "144 Route 17m Ste 4", "reason_for_recall": "Penicillin Cross Contamination: potentially contaminated with penicillin", "address_2": "", "product_quantity": "unknown", "code_info": "All lots", "center_classification_date": "20151202", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "BI-EST Suspensions, Rx, compounded by Life Science Pharmacy Inc., Harriman, NY", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Life Science Pharmacy Inc", "recall_number": "D-0499-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71494", "termination_date": "20180611", "more_code_info": "", "recall_initiation_date": "20150608", "postal_code": "10926-3321", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1382-2016", "product_description": "10 mcg/mL Fentanyl Citrate and 0.2% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride,\t 10 mL in 10 mL BD Syringe, Service Code 2T6203Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-203-27", "product_quantity": "740 BD syringes", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Lot Number 160380150M , Exp. Date 5/7/2016 ;  Lot Number 160420180M , Exp. Date 5/11/2016 ;  Lot Number 160450106M , Exp. Date 5/14/2016 ;  Lot Number 160480109M , Exp. Date 5/17/2016 ;  Lot Number 160660210M , Exp. Date 6/5/2016 ;  Lot Number 160700121M , Exp. Date 6/8/2016 ;  Lot Number 160770215M , Exp. Date 6/16/2016 ;  Lot Number 160820099M , Exp. Date 6/20/2016 ;  Lot Number 160880167M , Exp. Date 6/26/2016 ;  Lot Number 161080045M , Exp. Date 7/16/2016 ;", "more_code_info": ""}, {"status": "Terminated", "city": "Roxboro", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86251", "recalling_firm": "Open Book Extracts", "address_1": "317 Lucy Garrett Rd", "address_2": "", "postal_code": "27574-9789", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1564-2020", "product_description": "Just Hand Sanitizer (Ethyl Alcohol 73%) Single Use-Packs 100-count NDC 78065-2020-2 UPC 703123998598 (Single packs NDC 78065-2020-1 UPC 703123998659) Distributed by: Just Hand Sanitizer", "product_quantity": "2880 boxes", "reason_for_recall": "Labeling Not Elsewhere Classified: Product labeled to contain methanol", "recall_initiation_date": "20200807", "center_classification_date": "20200909", "termination_date": "20220222", "report_date": "20200916", "code_info": "Lot: ES9-200610", "more_code_info": ""}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0483-2018", "product_description": "Desoximetasone USP (Micronized) for prescription compounding,  5g, RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327, NDC 58597-8634-2.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #:  071015-1, Exp. 3/7/2018"}, {"country": "United States", "city": "Horsham", "address_1": "425 Privet Rd", "reason_for_recall": "CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements", "address_2": "", "product_quantity": "22820 bottles", "code_info": "TE36053A,TE36063A,  Exp. 06/16", "center_classification_date": "20140512", "distribution_pattern": "Nationwide", "state": "PA", "product_description": "METHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960,  NDC 0093-2932-01", "report_date": "20140521", "classification": "Class II", "openfda": {}, "recalling_firm": "Teva Pharmaceuticals USA", "recall_number": "D1292-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67811", "termination_date": "20141114", "more_code_info": "", "recall_initiation_date": "20140324", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Star", "state": "ID", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64619", "recalling_firm": "Palmer Natural Products", "address_1": "11665 W State St", "address_2": "N/A", "postal_code": "83669-5223", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, Idaho, California and Hong Kong.  This product can be ordered on line.", "recall_number": "D-231-2013", "product_description": "NOOTROPA COGNITIVE ENHANCEMENT SUPPLEMENT, 400 mg Aniracetam Capsules 60 count bottle, OTC Manufactured & Packaged in the USA for NOOTROPA.COM.  DEVELOPED BY: Digital Superfuture Limited Arntel Building 9B 148 Des Voeux Rd. Hong Kong.", "product_quantity": "672 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: The products are unapproved drugs", "recall_initiation_date": "20130311", "center_classification_date": "20130401", "termination_date": "20130807", "report_date": "20130410", "code_info": "Lot  HJLA,"}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1237-2022", "product_description": "Testosterone Enanthate (GSO) 100mg/ml, 2 mL-vial,  Room temperature, Tailor Made Compounding", "product_quantity": "93 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch#: 11102106A1, Exp 4/30/2022; 01142230A1, Exp 7/13/2022.", "more_code_info": ""}, {"country": "United States", "city": "Little Rock", "address_1": "8821 Knoedl Ct", "reason_for_recall": "Lack of assurance of sterility: Product bags leaking at seam.", "address_2": "", "product_quantity": "370 bags", "code_info": "LOT # 20170506@14, Use By: 08/04/17", "center_classification_date": "20170531", "distribution_pattern": "Nationwide in the USA", "state": "AR", "product_description": "fentaNYL (as citrate) in 0.9% Sodium Chloride injectable,10 mcg per mL, Total Volume 100 mL, Single Dose Container bag, (Total fentanyl Dose 1,000 mcg/100 mL) Preservative Free, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-0202-32", "report_date": "20170607", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals", "recall_number": "D-0873-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77314", "termination_date": "20180329", "more_code_info": "", "recall_initiation_date": "20170518", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1532-2014", "product_description": "L-Carnitine Injection USP 100 mg/ml, packaged in 30 ml vials, Sterile, For IM or Deep SQ Use, Multiple Dose Vial, Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us.", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0238-2016", "product_description": "Betamethasone Combo 10 mL (7 mg/mL), 10 mL Multi-Dose Vial,for IM & Regional Injection, Rx  only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3018-10", "product_quantity": "19,494 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Numbers: 20150104@4 BUD: 9/27/2015; 20150105@1 BUD: 10/27/2015; 20150107@25 BUD: 12/27/2015; 20150306@44 BUD: 11/29/2015; 20150704@49 BUD: 10/3/2015; 20150705@5 BUD: 11/1/2015; 20151106@17 BUD: 12/7/2015; 20151305@5 BUD: 11/8/2015; 20151806@19 BUD: 12/13/2015; 20152005@29 BUD: 11/15/2015; 20152205@7 BUD: 11/16/2015"}, {"status": "Completed", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94522", "recalling_firm": "Hikma Injectables USA Inc", "address_1": "36 Stults Rd", "address_2": "", "postal_code": "08810-1540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CO, GA, PA, SD, WA", "recall_number": "D-0508-2024", "product_description": "Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL syringe, Rx only, Hikma Injectables USA Inc, 36 Stults Road, Dayton, NJ 08810, NDC 63037-123-25", "product_quantity": "", "reason_for_recall": "Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.", "recall_initiation_date": "20240429", "center_classification_date": "20240523", "report_date": "20240529", "code_info": "Lot #: 240310003D, Exp 6/4/2024", "more_code_info": ""}, {"country": "United States", "city": "Monroe", "address_1": "810 Main St", "reason_for_recall": "Lack of Processing Controls:", "address_2": "", "product_quantity": "a) 6x5ml  b) 4x10 c) 1x15 ml bottles,", "code_info": "Lots:  a) 08012019@33 exp: 8/15/19,   07182019@66 exp: 8/01/19,   07182019@15 exp: 8/01/19,   07012019@46 exp. 08/31/19,   07082019@27 exp: 8/31/19,     b) 07082019@55 exp: 8/31/19;   07182019@55 exp: 08/31/19;   06242019@55 exp: 8/31/19;   06202019@16 exp: 8/31/19    c) 08052019@11 exp: 11/3/19", "center_classification_date": "20190912", "distribution_pattern": "Product was dispensed to patients", "state": "CT", "product_description": "10% Acetyl-L-Cysteine Ophthalmic Solutions, dispensed in a) 5ml, b) 10ml c) 15 ml, dropper bottles", "report_date": "20190918", "classification": "Class II", "openfda": {}, "recalling_firm": "Compounded Solutions in Pharmacy", "recall_number": "D-1854-2019", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "83722", "termination_date": "20200304", "more_code_info": "", "recall_initiation_date": "20190903", "postal_code": "06468-2809", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Beloeil", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84055", "recalling_firm": "8046255 Canada Inc. DBA Viatrexx", "address_1": "1360 Louis-Marchand St", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed to physicians Nationwide throughout the United States and Puerto Rico.", "recall_number": "D-0348-2020", "product_description": "Viatrexx-ANS/CNS, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0025, NDC 73069-039-41.", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.", "recall_initiation_date": "20191015", "center_classification_date": "20191114", "termination_date": "20201210", "report_date": "20191120", "code_info": "Lot Numbers: 19-S00027, Exp. May: 2020"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0142-2022", "product_description": "QUAD-MIX PAPAV 30/PHENTOL 4/PGE-1 40/ATROPINE 0.4 INJ *C6*  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 07192021:52 BUD: 11/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-882-2015", "product_description": "Rivaroxaban active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "200 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0616-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Female Libido, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955511526, NDC 57955-5515-2", "product_quantity": "606 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 020618E Exp. 02/20; 080916U Exp. 08/18; 102816C Exp. 10/19"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0896-2019", "product_description": "Dr. King's SafeCare Rx Claustrophobia, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955182023, NDC 57955-1822-2", "product_quantity": "20 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 120816D Exp. 12/19"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1059-2023", "product_description": "fentaNYL in 0.9% sodium chloride, 1000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-4", "product_quantity": "19,014 bags", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270499, 17-270500, 17-270503, 17-270511, 17-270518, 17-270544, Exp. 7/16/2023; 17-270778, 17-270779, Exp. 7/19/2023; 17-270957, 17-270958, 17-270959, 17-270965, 17-270972, 17-270982, 17-270984, 17-270985, Exp. 7/23/2023; 17-271043, Exp. 7/24/2023; 17-271232, 17-271240, 17-271266, Exp. 7/26/2023; 17-271326, 17-271327, 17-271328, 17-271329, 17-271341, 17-271342, Exp. 7/27/2023;  17-271399, 17-271400, 17-271401, Exp. 7/30/2023; 17-271481, 17-271482, 17-271483, 17-271488, 17-271489, 17-271491, 17-271510, Exp. 7/31/2023; 17-271590, 17-271661, Exp. 8/1/2023; 17-271655, 17-271656, 17-271668, 17-271675, 17-271677, Exp. 8/2/2023; 17-271759, Exp. 8/3/2023; 17-271825, Exp. 8/6/2023; 17-271880, 17-271881, 17-271885, Exp. 8/7/2023; 17-271939, 17-271941, 17-271942, 17-271952, 17-271961, Exp. 8/8/2023; 17-272017, 17-272018, 17-272066, Exp. 8/9/2023; 17-272107, Exp. 8/10/2023; 17-272211, Exp. 8/13/2023; 17-272354, 17-272356, 17-272365, 17-272376, 17-272380, Exp. 8/15/2023; 17-272448, 17-272450, 17-272455, 17-272467, 17-272468, Exp. 8/16/2023; 17-272532, 17-272537, 17-272548, 17-272550, Exp. 8/17/2023; 17-272597, 17-272598, 17-272602, 17-272624, 17-272644, 17-272652, Exp. 8/20/2023; 17-273020, Exp. 8/27/2023; 17-273062, 17-273066, 17-273067, Exp. 8/28/2023; 17-273234, 17-273239, 17-273240, 17-273241, 17-273243, 17-273244, Exp. 8/30/2023; 17-273410, 17-273419, 17-273420, 17-273422, 17-273435, 17-273439, Exp. 9/3/2023; 17-273609, Exp. 9/5/2023; 17-273673, 17-273701, 17-273727, Exp. 9/6/2023; 17-273860, 17-273863, 17-273864, 17-273868, Exp. 9/10/2023; 17-273976, Exp. 9/11/2023; 17-274051, Exp. 9/12/2023."}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1530-2019", "product_description": "Good to Go Hand Sanitizer (Ethyl Alcohol 62%), 1 FL OZ (30 mL), OTC, Made in China for Cashco Distributors Inc. 6430 N. E. Columbia Blvd Portland OR 97218", "product_quantity": "52,160", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20180601 Exp 5/31/2020, 20180604 Exp  6/3/2020, 20180820 Exp 8/19/2020, 20180821 Exp 8/20/2020, 20180822 Exp 8/21/2020"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0800-2022", "product_description": "Formula F9, Papaverine 0.9mg/ml . Phentolamine 0.1mg/ml . PGE 20mcg/mL Atropine 0.01mg/ml, Multi-Dose 10 ml vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC: 73198-0004-10", "product_quantity": "800 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: D41C19 BUD: 4/19/2022, I42C13 BUD: 9/13/2022, I42B13 BUD: 9/13/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0323-2017", "product_description": "Ultra Cocktail #2 (Methionine (L) 12.5mg/Inositol 25mg/Choline Chloride 25 mg/Methylcobalamin 300mcg/Carnitine (L) 170mg/Thiamine HCL 20mg/Riboflavin-5-Phosphate Sod 2mg/Pyridoxine HCL 2mg/Folic Acid 2mg/Ascorbic Acid 20mg/Chromium Picolinate 66mcg/Lidocaine HCL 10mg/mL), (30 ML and 10 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "123 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 05192016A (11/15/2016), 08032016B (12/31/2016), 08232016A (12/31/2016), 09292016C (01/31/2017)."}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091226"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["51079-208", "51079-209", "51079-210", "51079-211"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["3a398bf9-4f72-46b9-e063-6394a90af2d2"], "spl_set_id": ["7c1083b9-7a20-475d-ba12-4f5d0b53e601"], "package_ndc": ["51079-208-01", "51079-208-20", "51079-209-01", "51079-209-20", "51079-210-01", "51079-210-20", "51079-211-01", "51079-211-03"], "original_packager_product_ndc": ["0378-3950", "0378-3951", "0378-3952", "0378-3953"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "76802", "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "address_1": "1718 Northrock Ct", "address_2": "", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0622-2017", "product_description": "Atorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.., NDC 51079-208-20", "product_quantity": "1,527 cartons", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.", "recall_initiation_date": "20170321", "center_classification_date": "20170328", "termination_date": "20190315", "report_date": "20170405", "code_info": "Lot #: 3084288, Exp. 07/18", "more_code_info": ""}, {"status": "Ongoing", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86799", "recalling_firm": "Advanced Nutriceuticals, LLC", "address_1": "836 E 86th St", "address_2": "N/A", "postal_code": "46240-1806", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, CO, FL, IN, KY, OH, TX", "recall_number": "D-0137-2021", "product_description": "B12 for Injection, 2 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN", "product_quantity": "1 vials", "reason_for_recall": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.", "recall_initiation_date": "20201130", "center_classification_date": "20201211", "report_date": "20201223", "code_info": "Lot #1111202001, Exp 01/11/2021"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65642", "recalling_firm": "Church & Dwight Inc", "address_1": "469 N Harrison St", "address_2": "N/A", "postal_code": "08540-3510", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-797-2013", "product_description": "Sodium Bicarbonate Powder, CAS-144-55-8, Arm & Hammer, labeled as a) USP1 Grade, packaged in bags of various quantities, Church & Dwight Co, Inc., 469 N. Harrison St., Princeton, NJ 08543-5297; and b) Sodium Bicarbonate U.S.P. No. 1 Powdered, Net Wt. 50 lbs. (22.68 kg.) per bag, Manufactured by: Church & Dwight Co., Inc., 469 N. Harrison St., Princeton, N.J. 08543-5297, Product #60111.", "product_quantity": "749 tons total", "reason_for_recall": "Presence of Foreign Substance: raw material recalled due to stainless steel and other contamination.", "recall_initiation_date": "20130611", "center_classification_date": "20130712", "termination_date": "20150630", "report_date": "20130724", "code_info": "Lot #: FF3153, FF3154, FF3155, FF3156, FF3157, and FF3158"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "120 pellets", "code_info": "All lots distributed between November 2014 and May 2015;  12082014@58, 6/6/2015; 02032015@42, 7/1/2015; 02272015@28, 8/26/2015; 03242015@97, 9/20/2015; 05052015@62, 11/1/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Estradiol 20 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1469-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-247-2014", "product_description": "Mitomycin 2ml (full Strength), Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "32 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80397", "recalling_firm": "Aidarex Pharmaceuticals LLC", "address_1": "595 N Smith Ave", "address_2": "N/A", "postal_code": "92880-6920", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0992-2018", "product_description": "Enalapril Maleate, USP 5MG, 30-count bottle, RX only. Packaged By: Aidarex Pharmaceuticals. Mfg: Wockhardt Ltd. India.  NDC: 33261-0693-30", "product_quantity": "25, 30-count bottles", "reason_for_recall": "Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.", "recall_initiation_date": "20180627", "center_classification_date": "20180725", "termination_date": "20191204", "report_date": "20180801", "code_info": "Lots: 51904-2, EXP: 01/31/2018; 51904-3, EXP: 02/28/2018; 51904-5, EXP: 03/31/2018; 52885-2, EXP: 03/31/2018, 53840-1, EXP: 5/28/2018."}, {"status": "Terminated", "city": "Newport Beach", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85942", "recalling_firm": "UVT INC", "address_1": "5000 Birch St", "address_2": "Ste. 3000", "postal_code": "92660-2127", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to two wholesalers in FL who may have further distributed Nationwide in the USA.", "recall_number": "D-1407-2020", "product_description": "Saniderm ADVANCED HAND SANITIZER, 70% Alcohol Content, 1 Liter bottles, Distributed by Polarized, LLC, Produced by Eskbiochem SA de CV, Mexico Japon 50, Celaya, Gto., Mexico, 38010. UPC 8 60003 63391 5.", "product_quantity": "38,016 bottles", "reason_for_recall": "Chemical Contamination: Product contains undeclared methanol.", "recall_initiation_date": "20200622", "center_classification_date": "20200724", "termination_date": "20231128", "report_date": "20200805", "code_info": "Lot 0530, Exp. Date 04/22"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82619", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-1205-2019", "product_description": "Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in (a) 150 mL bottle (NDC 0093-4150-80) (b) 80 mL bottle (NDC 0093-4150-79), Rx Only, Manufactured in Canada By: Teva Canada Limited Toronto, Canada, M1B2K9, Manufactured For: Teva Pharmaceuticals USA, INC. North Wales, PA 19454.", "product_quantity": "171,488 150 mL and 80 mL bottles", "reason_for_recall": "Subpotent Product: assay results for Amoxicillin were below the specification limits.", "recall_initiation_date": "20190412", "center_classification_date": "20190418", "termination_date": "20200708", "report_date": "20190424", "code_info": "Lots: (a) Lot # 35436769A, exp. date 05/2019; 35438389A, 35438390A, exp. date 01/2020; 35440838A, exp. date 10/2020; (b) 35437491A, 35443574B, exp. date 09/2021"}, {"country": "United States", "city": "Union", "address_1": "675 Rahway Ave", "reason_for_recall": "Labeling: Not elsewhere classified; product labeling lacks a NDC number, net weight information and does not contain the Drug Facts Panel.", "address_2": "", "product_quantity": "2,634 bottles (58 bottles/5mL & 2576 bottles/15 mL)", "code_info": "all lots  Expiration date August 2019", "center_classification_date": "20170524", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Refresh Tears (Carboxymethylcellulose Sodium Solution) 0.5%, Lubricant Eye Drops, Sterile packaged as 1) two 15 mL bottles, USPC Code 784190442214, 2) 4x15 mL and one 5 mL bonus bottles, USPC Code 069886941746, Distributed by Cell Distributors, Union, NJ", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Cell Distributors", "recall_number": "D-0865-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76861", "termination_date": "20190618", "more_code_info": "", "recall_initiation_date": "20170403", "postal_code": "07083-6683", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: METHAZOLAMIDE, Tablet, 50 mg may have potentially been mislabeled as the following drug:  BUPRENORPHINE HCL SL, Tablet, 2 mg, NDC 00054017613, Pedigree: AD39573_1, EXP: 5/13/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "METHAZOLAMIDE, Tablet, 50 mg has the following codes:   Pedigree: AD37072_11, EXP: 5/13/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "METHAZOLAMIDE, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781107101.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-999-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-126-2014", "product_description": "HCG 260 iu prefilled syringes, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "6 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0424-2020", "product_description": "Altaire Sterile Eye Wash, 30 mL (1 fl oz.), Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-175-18", "product_quantity": "414,346 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17200 7/19   17322 10/20   18026 1/21   18100 4/21   18236 9/21   19052 2/22"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-988-2013", "product_description": "PHOSPHATIDYLCHOLINE 50 MG/ML INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "07082013@26", "more_code_info": ""}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0189-2016", "product_description": "BIEST TD 67/33 (Estradiol (E2) TRIT (YELLOW)/Estriol USP Micronized (E3)) W/V (weight /volume) 1.5 MG/ML Transdermal cream, dispensed in 3 mL prefilled, amber syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "10 (3mL) syringes", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 03022015:71@18, Exp 8/29/2015"}, {"country": "United States", "city": "Staten Island", "address_1": "119 Linwood Ave", "reason_for_recall": "Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.", "address_2": "", "product_quantity": "unknown", "code_info": "All Lots", "center_classification_date": "20180228", "distribution_pattern": "NY and NJ through six retail stores named \"Asian Food Markets\"", "state": "NY", "product_description": "GERMANY BLACK GOLD tablets, 2800 mg, 8-count bottle, labeling is in foreign language", "report_date": "20180207", "classification": "Class I", "openfda": {}, "recalling_firm": "A&H Focal Inc.", "recall_number": "D-0555-2018", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "76644", "termination_date": "20190614", "more_code_info": "", "recall_initiation_date": "20170307", "postal_code": "10305-4445", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA072204"], "brand_name": ["LOXAPINE"], "generic_name": ["LOXAPINE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-0369", "0591-0370", "0591-0371", "0591-0372"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOXAPINE SUCCINATE"], "rxcui": ["311385", "311386", "314075", "314078"], "spl_id": ["cae2db34-6be2-45cf-b9b5-9b929650eb4f"], "spl_set_id": ["a6107bb1-3e23-4c5d-bbf4-5e29deff6728"], "package_ndc": ["0591-0369-01", "0591-0370-01", "0591-0371-01", "0591-0372-01"], "is_original_packager": [true], "upc": ["0305910369019", "0305910370015", "0305910372019"], "unii": ["X59SG0MRYU"]}, "product_type": "Drugs", "event_id": "62383", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1402-2012", "product_description": "Loxapine Capsules USP, 50mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC #  0591-0372-01", "product_quantity": "18,902 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert:  An outdated version of a patient outsert was used when packaged.", "recall_initiation_date": "20120417", "center_classification_date": "20120629", "termination_date": "20130318", "report_date": "20120711", "code_info": "Lot #s: 104432A, 104433A, 121344A, 127024A, 144290A"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62591", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "200 Somerset Corporate Blvd Fl 7th", "address_2": "N/A", "postal_code": "08807-2862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1435-2012", "product_description": "Dr. Reddy's Ciprofloxacin Tablets, USP 500 mg*, 500 Tablets, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-127-05", "product_quantity": "1656 bottles", "reason_for_recall": "Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets", "recall_initiation_date": "20120409", "center_classification_date": "20120731", "termination_date": "20130124", "report_date": "20120808", "code_info": "C201293  Exp Date 08/2013"}, {"status": "Terminated", "city": "Melrose Park", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA074893"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-469", "63323-471"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859867", "859871", "1719803", "1719862"], "spl_id": ["86dff2aa-2ab3-42fc-989e-619b13ace573"], "spl_set_id": ["ca9896e0-fb2e-46a4-8700-20d144c14764"], "package_ndc": ["63323-469-01", "63323-469-05", "63323-471-01", "63323-471-05"], "is_original_packager": [true], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "68019", "recalling_firm": "Fresenius Kabi USA LLC", "address_1": "2020 N Ruby St", "address_2": "", "postal_code": "60160-1112", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0247-2015", "product_description": "HALOPERIDOL DECANOATE INJECTION, 50 mg/mL, 1 mL vial, Rx only, Fresenius Kabi USA, LLC, Schaumburg, IL 60173 NDC  63323-469-01", "product_quantity": "216,517 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: Fresenius Kabi is recalling three lots of Haloperidol Decanoate Injection due to an out-of-specification result.", "recall_initiation_date": "20140414", "center_classification_date": "20141113", "termination_date": "20160308", "report_date": "20141119", "code_info": "Lot  6105149, Exp.05/14; 6105696, Exp. 07/14; 6105836, Exp. 08/14; Lot 6106516, Exp. 12/14; Lot 6106837, Exp. 02/15", "more_code_info": ""}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["NP THYROID 60"], "generic_name": ["LEVOTHYROXINE, LIOTHYRONINE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-330"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE", "LIOTHYRONINE"], "rxcui": ["313391", "1724481"], "spl_id": ["1eed1f06-6d04-4057-87ed-782c6850e7d2"], "spl_set_id": ["f347f490-7199-4de6-bca2-0d44a74979af"], "package_ndc": ["42192-330-30", "42192-330-01", "42192-330-10"], "is_original_packager": [true], "upc": ["0342192330108"], "nui": ["N0000175945", "M0021504", "N0000175946", "M0021977"], "pharm_class_epc": ["l-Thyroxine [EPC]", "l-Triiodothyronine [EPC]"], "pharm_class_cs": ["Thyroxine [CS]", "Triiodothyronine [CS]"], "unii": ["Q51BO43MG4", "06LU7C9H1V"]}, "product_type": "Drugs", "event_id": "87843", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110-B", "address_2": "N/A", "postal_code": "30005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States including Puerto Rico", "recall_number": "D-0397-2021", "product_description": "NP Thyroid 60 Thyroid Tablets, USP 1 grain (60 mg) 100-count bottles, Rx Only Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-330-01", "product_quantity": "154,726 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210429", "center_classification_date": "20210524", "termination_date": "20240313", "report_date": "20210602", "code_info": "Lots: M330D20-1, M330D20-2 Exp. 03/31/2022; M330J19-2A,  M330J19-4A , M330J19-5A,  M330J19-6A, M330J19-7A, M330J19-9A Exp. 08/31/2021; M330K19-10, M330K19-1A, M330K19-9 Exp. 09/30/2021"}, {"country": "United States", "city": "Princeton", "address_1": "107 College Rd E", "reason_for_recall": "Failed Impurities/Degradation Specifications: OOS for unknown impurities.", "address_2": "", "product_quantity": "10,530 vials", "code_info": "Batch Numbers: BS704, EXP 12/018;  BS725, EXP 6/2019; BS745, EXP 11/2019.", "center_classification_date": "20181026", "distribution_pattern": "Product was distributed to retailers, distributors, physician officers and medical facilities throughout the United States.", "state": "NJ", "product_description": "Zoledronic Acid Injection, 5 mg/100 mL (0.05 mg/mL) One 100ml Single-Dose Bottle, Rx Only. NOVAPLUS Mfd By: Gland Pharma Limited D.P. Pally - 500 043 India: Mfd. For: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India. N+ and NOVAPLUS are registered trademarks of Vizient, Inc. NDC 43598-331-11", "report_date": "20181003", "classification": "Class III", "openfda": {"application_number": ["ANDA091363"], "brand_name": ["ZOLEDRONIC ACID"], "generic_name": ["ZOLEDRONIC ACID"], "manufacturer_name": ["Dr.Reddy's Laboratories Inc"], "product_ndc": ["43598-331"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ZOLEDRONIC ACID"], "rxcui": ["705824"], "spl_id": ["d89899a3-8ada-0438-07b9-2164c640995a"], "spl_set_id": ["c8e02635-4473-8ba2-248f-ced58dbeabce"], "package_ndc": ["43598-331-11"], "is_original_packager": [true], "unii": ["6XC1PAD3KF"]}, "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "recall_number": "D-0104-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81012", "termination_date": "20200303", "more_code_info": "", "recall_initiation_date": "20180912", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0509-2022", "product_description": "FEM-PRIN MENSTRUAL RELIEF (acetaminophen 325 mg, pamabrom 25mg) tablets, 2-count packets, Manufactured for: HARTHealth Seattle, WA 98124", "product_quantity": "223,090 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9695, Exp. Date 07/2022"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2665", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Ephedrine Sulfate 5 mg/mL in 0.9% Sodium Chloride, 10 mL BD syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0961-72", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1336-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "unknown", "code_info": "Lot #: 20130116-A, Exp 04/16/13", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Amikacin Injection, all strengths and all presentations including 50, 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-341-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA016964"], "brand_name": ["MARCAINE"], "generic_name": ["BUPIVACAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-0525", "0409-1559", "0409-1560", "0409-1582", "0409-1587", "0409-1610", "0409-1746", "0409-1749", "0409-1752", "0409-1755", "0409-2510", "0409-7535", "0409-1250", "0409-5010", "0409-1530", "0409-7510", "0409-2253"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["PERINEURAL"], "substance_name": ["BUPIVACAINE HYDROCHLORIDE"], "rxcui": ["1012377", "1012381", "1012384", "1012388", "1012396", "1012400", "1012404", "1012406", "1672917", "1672919", "1673242", "1673243", "1724786", "1724787", "1724794", "1724796", "1724880", "1724884", "1725044", "1725046", "1725078", "1725079", "1725082", "1725083", "1867594", "1867596", "1867612", "1867614"], "spl_id": ["b00b78c3-c70d-49b9-a381-6a1496f74153"], "spl_set_id": ["67578b56-7540-487e-1fba-481255620e78"], "package_ndc": ["0409-1559-18", "0409-1559-10", "0409-1559-19", "0409-1559-30", "0409-1560-18", "0409-1560-10", "0409-1560-19", "0409-1560-29", "0409-1582-18", "0409-1582-10", "0409-1582-19", "0409-1582-29", "0409-1587-50", "0409-1610-50", "0409-1746-70", "0409-1746-10", "0409-1746-71", "0409-1746-30", "0409-1749-70", "0409-1749-10", "0409-1749-71", "0409-1749-29", "0409-1752-50", "0409-1755-50", "0409-2510-01", "0409-2510-25", "0409-7535-01", "0409-7535-25", "0409-1250-01", "0409-1250-25", "0409-5010-01", "0409-5010-25", "0409-1530-01", "0409-1530-25", "0409-0525-01", "0409-0525-25", "0409-7510-01", "0409-7510-25", "0409-2253-01", "0409-2253-25"], "is_original_packager": [true], "unii": ["7TQO7W3VT8", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "68579", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0002-2015", "product_description": "Marcaine (bupivacaine HCl) injection, USP, 0.5%, Preservative-Free, 30 mL (150 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045   NDC 0409-1560-29", "product_quantity": "40,730 vials", "reason_for_recall": "Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.", "recall_initiation_date": "20140617", "center_classification_date": "20141001", "termination_date": "20170403", "report_date": "20141008", "code_info": "Lot # 33-545-DD, Exp. 09/15"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83996", "recalling_firm": "Coast Quality Pharmacy, LLC dba Anazao Health", "address_1": "5710 Hoover Blvd", "address_2": "N/A", "postal_code": "33634-5339", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0604-2020", "product_description": "Fentanyl Citrate and Bupivacaine HCL and Clonidine HCL in all strengths, all doses and all packaging,  AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.", "recall_initiation_date": "20190903", "center_classification_date": "20191206", "termination_date": "20201201", "report_date": "20191218", "code_info": "All lots filled and dispensed on 08/26-29/2019 and 09/27/2019 through 10/03/2019 remaining within expiry.", "more_code_info": ""}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "A5011 Exp 11/30/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Enrofloxacin 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-726-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Boerne", "address_1": "38505 Interstate 10 W", "reason_for_recall": "Superpotent: Drug product active ingredients were formulated incorrectly (too high) with respect to the label strength.", "address_2": "", "product_quantity": "8,437 bottles", "code_info": "Lot# E112, Exp 05/14    Lot# J062,  Exp 09/14", "center_classification_date": "20130614", "distribution_pattern": "Nationwide", "state": "TX", "product_description": "Sodium Sulfacetamide 10% and Sulfur 5% Lotion, (NDC 42792-102-01), 25 g Manufactured for:  Austin Pharmaceuticals, LLC, Wilmington, DE", "report_date": "20130626", "classification": "Class III", "openfda": {}, "recalling_firm": "Mission Pharmacal Co", "recall_number": "D-602-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64149", "termination_date": "20140318", "more_code_info": "", "recall_initiation_date": "20130123", "postal_code": "78006-8914", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Wilmington", "address_1": "1800 Concord Pike", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM\u00bf capsules contained 60 SEROQUEL\u00bf  XR tablets.", "address_2": "", "product_quantity": "34,524 bottles", "code_info": "Lot # FC0064; Exp. 05/17", "center_classification_date": "20150618", "distribution_pattern": "Nationwide to wholesalers for further distribution at the retail level.", "state": "DE", "product_description": "NEXIUM\u00bf (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31.", "report_date": "20150624", "classification": "Class II", "openfda": {}, "recalling_firm": "AstraZeneca Pharmaceuticals LP", "recall_number": "D-1141-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "71483", "termination_date": "20160927", "more_code_info": "", "recall_initiation_date": "20150610", "postal_code": "19850", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0747-2018", "product_description": "Botox 100 Units Vial NDC 00023-1145-01 90 days supply.", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M016"], "brand_name": ["CHAPSTICK TOTAL HYDRATION MOISTURE TINT VERY BERRY"], "generic_name": ["ZINC OXIDE"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0573-0872"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ZINC OXIDE"], "spl_id": ["fdf6710f-a51c-4b5f-b4c6-c29579584b91"], "spl_set_id": ["59023150-65ef-4427-9045-0e64b100cbab"], "package_ndc": ["0573-0872-08", "0573-0872-11"], "is_original_packager": [true], "unii": ["SOI2LOH54Z"]}, "product_type": "Drugs", "event_id": "85500", "recalling_firm": "Glaxosmithkline Consumer Healthcare Holdings", "address_1": "184 Liberty Corner Rd", "address_2": "N/A", "postal_code": "07059-6796", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1267-2020", "product_description": "ChapStick Total Hydration Moisture + Tint + SPF15 Very Berry  Net Wt. 0.08 OZ (2.2g) Marketed by: Pfizer, Madison, NJ 07940 USA NDC 0573-0872-08", "product_quantity": "288 packages", "reason_for_recall": "Labeling: Not elsewhere classified: Observed separation in the secondary packaging in the blister and the backer card", "recall_initiation_date": "20200420", "center_classification_date": "20200513", "termination_date": "20211026", "report_date": "20200520", "code_info": "Lot #: 9346AA, 9347AA"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0324-2017", "product_description": "Ultra Slim Shot (Methionine (L) 25mg/Inositol 50mg/Choline Chloride 50 mg/Methylcobalamin 1mg/Carnitine (L) 170mg/Pyridoxine HCL 2mg/Lidocaine HCL 10mg/mL), (30 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "874 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 06232016C (12/20/2016), 07272016B (12/31/2016), 08232016B (01/31/2017), 10262016D (02/28/2017), 09202016C (03/19/2016)."}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0683-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 10% with CALCIUM, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0405-1.", "product_quantity": "558 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-893806, Exp 04/28/2023; 37-894701, Exp 04/30/2023; 37-895626, Exp 05/05/2023; 37-897277, Exp 05/12/2023; 37-899175, Exp 05/19/2023; 37-900971, Exp 05/26/2023"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-1024-2016", "product_description": "VITAMIN B COMPLEX # 3, packaged in 5mL vials, Rx only,   Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 01052016:13@44, Exp.03/07/2016; Lot #: 01052016:    06@43, Exp. 04/13/2016; Lot #: 04052016:84@24; Exp. 06/06/2016."}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA077908"], "brand_name": ["PROPOFOL"], "generic_name": ["PROPOFOL"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4699", "0409-6010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PROPOFOL"], "rxcui": ["1808217", "1808222", "1808224"], "spl_id": ["d55c0318-811d-4624-aa0c-456182f7b019"], "spl_set_id": ["28d7ba00-f824-4e55-139a-03f509c099db"], "package_ndc": ["0409-4699-50", "0409-4699-30", "0409-4699-53", "0409-4699-33", "0409-4699-54", "0409-4699-24", "0409-6010-02", "0409-6010-25"], "is_original_packager": [true], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["YI7VU623SF"]}, "product_type": "Drugs", "event_id": "90785", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-1540-2022", "product_description": "PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of 10 vials (NDC Carton: 0409-4699-24), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA", "product_quantity": "5,390 vials", "reason_for_recall": "Presence of particulate matter", "recall_initiation_date": "20220822", "center_classification_date": "20220919", "termination_date": "20250630", "report_date": "20220921", "code_info": "Lot#: EA7470, Exp 6/1/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0815-2019", "product_description": "Dr. King's SafeCare Rx VaccinoClenz, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955003224, NDC 57955-0082-2", "product_quantity": "494 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 081015F Exp. 08/18; 050216Y Exp. 05/19; 090116C Exp. 09/19"}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075784"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-161", "63323-162"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["860092", "1665459", "1665461"], "spl_id": ["ab476c4c-2c72-47b1-bf42-7a89703b0dd4"], "spl_set_id": ["d1920335-8e45-4960-b6e9-e6f1f9e6820c"], "package_ndc": ["63323-161-00", "63323-161-01", "63323-162-11", "63323-162-51", "63323-162-00", "63323-162-01", "63323-162-03", "63323-162-02"], "is_original_packager": [true], "upc": ["0363323162115", "0363323161002", "0363323162009", "0363323162030"], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "87005", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "N/A", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide and Puerto Rico", "recall_number": "D-0184-2021", "product_description": "Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-162-02", "product_quantity": "490,633 vials", "reason_for_recall": "Presence of Particulate Matter - found in reserve sample vials at the firm.", "recall_initiation_date": "20201217", "center_classification_date": "20201231", "termination_date": "20230620", "report_date": "20210106", "code_info": "Batch # 6121125, Exp 02/2021"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88738", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0022-2022", "product_description": "AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Sample Not For Sale,  Rx Only, Mktd by: Teva Respiratory, LLC, Frazer, PA 19355, Manufactured in Ireland, NDC 59310-530-08.", "product_quantity": "3,240 inhalers", "reason_for_recall": "Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol", "recall_initiation_date": "20210922", "center_classification_date": "20211021", "termination_date": "20230216", "report_date": "20211027", "code_info": "AFR18A"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-458-2013", "product_description": "PGE-1 Inj 20mcg/ml MDV: 5ml, 7ml, 10ml, 20ml  Penile Injection, 90 day expiration,", "product_quantity": "37", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Ongoing", "city": "Elkins Park", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97831", "recalling_firm": "ibspot", "address_1": "1414 Willow Ave", "address_2": "", "postal_code": "19027-3147", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "WY and VA", "recall_number": "D-0098-2026", "product_description": "Taoscare Motion Sickness Patches 36-count box, Henan Xinyongtal Medical Technology., Ltd., Address: he nan sheng zhou kou shi huai yang xian gong ye yuan qu, X003SR097N", "product_quantity": "3 boxes", "reason_for_recall": "Marketed Without an Approved NDA/ANDA", "recall_initiation_date": "20251009", "center_classification_date": "20251023", "report_date": "20251029", "code_info": "none", "more_code_info": ""}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1818-2019", "product_description": "VINCRISTINE 1 MG /50 ML NS IVPB; VINCRISTINE 1.2 MG /50 ML NACL 0.9% IVPB; VINCRISTINE 1 MG / 1 ML IVP SYRINGE; VINCRISTINE 2 MG /100 ML D5W IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0248-2020", "product_description": "S-QUADMIX (30MG/2MG/20MCG/0.15MG/ML) MDV INJ, Rx Only, 5ml Glass vial. Red Mountain Compounding Rx.", "product_quantity": "2x5ml Glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S06302019DH@03, Exp 8/30/19"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0904-2019", "product_description": "Aquaflora Heavy Metal Detox Candida, 2 fl. oz. (59 mL), Homeopathic, King Bio, Inc. 3 Westside Dr. Asheville, NC 28806 USA, NDC 57955-2281-2", "product_quantity": "2086 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 080216A Exp. 08/19"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-453-2013", "product_description": "Bimix Inj 30 :1 Syr, 12x1.5 ml syr, 10x1.2 ml syr, 2x2 ml syr, 2x1 ml syr, 12x.05 ml syr  Penile Injection,30 and 90 day expiration,", "product_quantity": "5", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77634", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0993-2017", "product_description": "Potassium PHOSphate in 5% Dextrose Injection, 7.5 mMol in 100 mL in 150 mL Intravia Bag, Rx Only, PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478 800-523-7749 Service Code 2K5299 NDC# 61553-299-48", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; media fill failure at manufacturer", "recall_initiation_date": "20170626", "center_classification_date": "20170714", "termination_date": "20200429", "report_date": "20170726", "code_info": "Lot: 171450017D, 8/24/2017"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70148", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-455-2015", "product_description": "Truman Medical Center Lakewood (MO) Starter TPN, Trophamine 5.25g, Dextrose 10%, Additives: Calcium Gluconate 4.8mEq, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.", "product_quantity": "5 bags", "reason_for_recall": "Non-Sterility: Out of specification results for the sterility test for microbial contamination.", "recall_initiation_date": "20141217", "center_classification_date": "20150408", "termination_date": "20150819", "report_date": "20150415", "code_info": "lot number 37-74700, Made on 15 DEC 2014, EXP 24 DEC 2014, CAPS Rx: 37-74700-0-1-R, Disp ID: 37-1124575"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78320", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0062-2018", "product_description": "fentanyl as citrate 2 mcg per mL BUPIvacaine HCl 0.125% (Total FentaNYL Dose 500 mcg/250 mL) in 0.9% Sodium Chloride 250 mL Bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205. NDC 70004-0231-40", "product_quantity": "116 bags", "reason_for_recall": "Lack Of Assurance Of Sterility.", "recall_initiation_date": "20171019", "center_classification_date": "20171102", "termination_date": "20190501", "report_date": "20171108", "code_info": "Lot: 20170814@20 BUD: 11/12/2017"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82941", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "FDA Mandated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1332-2019", "product_description": "Sermorelin/GHRP-2 9 mg/6 mg vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846", "product_quantity": "66 vials", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20190523", "center_classification_date": "20190607", "termination_date": "20210205", "report_date": "20190619", "code_info": "Lot #: 03052019:43 Exp. 08/31/2019; 04042019:15 Exp. 10/01/2019; 04172019:08 Exp. 08/31/2019; 05022019:47 Exp. 10/30/2019; 05082019:78 Exp. 06/04/2019"}, {"status": "Terminated", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA203952"], "brand_name": ["DUOPA"], "generic_name": ["CARBIDOPA AND LEVODOPA"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-3012"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ENTERAL"], "substance_name": ["CARBIDOPA", "LEVODOPA"], "rxcui": ["1599846", "1599852"], "spl_id": ["df03067f-7374-4da4-852f-827a421a41d2"], "spl_set_id": ["7066d371-dc6a-0d6f-7bed-e5dd4ee912da"], "package_ndc": ["0074-3012-07"], "is_original_packager": [true], "upc": ["0300743012071"], "nui": ["N0000175754", "N0000175755", "N0000193220", "M0370111"], "pharm_class_epc": ["Aromatic Amino Acid Decarboxylation Inhibitor [EPC]", "Aromatic Amino Acid [EPC]"], "pharm_class_moa": ["DOPA Decarboxylase Inhibitors [MoA]"], "pharm_class_cs": ["Amino Acids, Aromatic [CS]"], "unii": ["MNX7R8C5VO", "46627O600J"]}, "product_type": "Drugs", "event_id": "76199", "recalling_firm": "AbbVie Inc.", "address_1": "1 N Waukegan Rd", "address_2": "N/A", "postal_code": "60064-1802", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "TN and IL", "recall_number": "D-0495-2017", "product_description": "Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassette, 7 cassettes per carton, Rx Only, AbbVie Inc., North Chicago, IL 60064 --- NDC 0074-3012-07", "product_quantity": "4021 cartons, 7 100-mL cassettes each", "reason_for_recall": "Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life", "recall_initiation_date": "20170113", "center_classification_date": "20170227", "termination_date": "20190315", "report_date": "20170308", "code_info": "Lots:  1055692, Expiration Date (Frozen) 06/01/2018  1057881, Expiration Date (Frozen) 06/02/2018  1060138, Expiration Date (Frozen) 06/13/2018  1060140, Expiration Date (Frozen) 06/15/2018  1061258, Expiration Date (Frozen) 06/17/2018  1061262, Expiration Date (Frozen) 06/30/2018  1063033, Expiration Date (Frozen) 07/14/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0214-2016", "product_description": "ESTRIOL (E3)  4.0MG capsules,  Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "90 capsules", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 01142015:26@28, Exp 1/14/2016"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207068"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-008", "16729-009", "16729-010", "16729-011"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["0e03244d-61de-bb5f-e063-6294a90a671c"], "spl_set_id": ["6c011348-a236-47d3-bbef-3e0b956dd080"], "package_ndc": ["16729-008-15", "16729-008-16", "16729-008-17", "16729-009-15", "16729-009-16", "16729-009-17", "16729-010-15", "16729-010-16", "16729-010-17", "16729-011-15", "16729-011-16", "16729-011-17"], "is_original_packager": [true], "unii": ["3M8608UQ61"], "upc": ["316729010177"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0423-2023", "product_description": "Pravastatin Sodium Tablets USP, 40 mg, Rx Only, 1,000-count bottle Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA.  NDC 16729-010-17, UPC 3 16729 01017 7", "product_quantity": "120 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches:  R2201294, Exp. Date 8/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "72733", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0510-2016", "product_description": "MECLIZINE HYDROCHLORIDE TABLETS, 25 mg, Packaged in a) 100 ct Bottles (NDC: 60429-205-01) and b) 1000 ct Bottles (NDC: 60429-205-10), Rx Only.  Manufactured by: Par Pharmaceuticals Companies Inc., Spring Valley, NY 10977. Packaged by: GSMS Incorporated, Carmarillo, CA 93012.", "product_quantity": "a) 737 Bottles; b) 3863 Bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for impurities.", "recall_initiation_date": "20151125", "center_classification_date": "20151204", "termination_date": "20160607", "report_date": "20151216", "code_info": "a)  Lot #: GS005224, Expiry: Jul-16, Lot:#: GS007553, Expiry: Nov-17; Lot #: GS007858, Expiry: Nov-17. b)   Lot #: GS002674, Expiry: Jan-16; Lot #: GS003402, Expiry:May-16; Lot #: GS003582, Expiry: Jun-16; Lot #: GS004899, Expiry: Jun-16; Lot #: GS005908, Expiry: Jun-17; Lot #: GS006088, Expiry: Jun-17; Lot #: GS006254, Expiry: Sep-17; Lot #: GS007345, Expiry: Nov-17; Lot #: GS007664, Expiry: Nov-17; Lot #: GS007803, Expiry: Nov-17; Lot #: GS008091, Expiry: Nov-17.", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205530"], "brand_name": ["ACETAZOLAMIDE"], "generic_name": ["ACETAZOLAMIDE"], "manufacturer_name": ["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."], "product_ndc": ["23155-287", "23155-288"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ACETAZOLAMIDE"], "rxcui": ["197303", "197304"], "spl_id": ["9538a2b5-9fb4-4b51-96e6-e21106d583d7"], "spl_set_id": ["0700a910-79aa-4431-aecf-637fe14fcae8"], "package_ndc": ["23155-287-10", "23155-287-01", "23155-288-01", "23155-288-10"], "is_original_packager": [true], "upc": ["0323155288100", "0323155287103", "0323155287011", "0323155288018"], "nui": ["N0000175517", "N0000000235", "M0020790"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "pharm_class_cs": ["Sulfonamides [CS]"], "unii": ["O3FX965V0I"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0490-2021", "product_description": "AcetaZOLAMIDE Tablets, USP 125 mg 100 Tablets Rx only NDC 23155-287-01 Manufactured for: Heritage Pharmaceuticals Inc. Eatontown, NJ 07724", "product_quantity": "122 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "M200833"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA206185"], "brand_name": ["XELPROS"], "generic_name": ["LATANOPROST"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-317"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC", "TOPICAL"], "substance_name": ["LATANOPROST"], "rxcui": ["2056743", "2056748"], "spl_id": ["f3427f6d-e577-4e72-b9a8-b149338ce838"], "spl_set_id": ["34ad5cf6-4df0-4104-bddd-4c7631133ded"], "package_ndc": ["47335-317-90", "47335-317-98", "47335-317-92", "47335-317-94"], "is_original_packager": [true], "nui": ["N0000175454", "M0017805"], "pharm_class_epc": ["Prostaglandin Analog [EPC]"], "pharm_class_cs": ["Prostaglandins [CS]"], "unii": ["6Z5B6HVF6O"]}, "product_type": "Drugs", "event_id": "94465", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX, PA", "recall_number": "D-0502-2024", "product_description": "Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., India., NDC 47335-317-90", "product_quantity": "35,069 bottles", "reason_for_recall": "Failed Release Testing: Out of specification for particulate matter test.", "recall_initiation_date": "20240422", "center_classification_date": "20240520", "report_date": "20240529", "code_info": "Lot #: HAD3383A, Exp 8/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-572-2015", "product_description": "Cephalexin Monohydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "2000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA011245"], "brand_name": ["GASTROGRAFIN"], "generic_name": ["DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM"], "manufacturer_name": ["Bracco Diagnostics Inc"], "product_ndc": ["0270-0445"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL", "RECTAL"], "substance_name": ["DIATRIZOATE MEGLUMINE", "DIATRIZOATE SODIUM"], "spl_id": ["7c17ff73-033f-4c13-b31d-3f84a9f88768"], "spl_set_id": ["8c2340e4-2b42-45dc-8fac-9960e8172547"], "package_ndc": ["0270-0445-35", "0270-0445-40"], "is_original_packager": [true], "upc": ["0302700445403"], "unii": ["3X9MR4N98U", "V5403H8VG7"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1086-2022", "product_description": "Gastrografin (Diatrizoate Meglumine and Diatrizoate Sodium Solution USP), packaged in: Twenty-four 30 mL single dose bottles, Rx only, MFG: Bracco Diagnostics Inc., NDC 0270-0445-35", "product_quantity": "1 case", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["BASIC CARE NO DRIP NASAL"], "generic_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["Amazon.com Services LLC"], "product_ndc": ["72288-388"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["b6f50e61-ad28-417f-8ede-e543084f4ab3"], "spl_set_id": ["96e018e2-e0b5-4802-a4a1-73a73d574082"], "package_ndc": ["72288-388-10"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0614-2022", "product_description": "Maximum Strength No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL) per bottle,  DISTRIBUTED BY: AMAZON.COM SERVICES LLC, 410 TERRY AVENUE N. SEATTLE, WA 9810. NDC 72288-388-10", "product_quantity": "26,448 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1BK0826, Exp 12/31/2022); 1BK0964R, Exp 01/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205050"], "brand_name": ["TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"], "generic_name": ["TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-9651"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TRAVOPROST"], "rxcui": ["284008"], "spl_id": ["7a6a2083-70a0-4089-88f0-9ddc088376ce"], "spl_set_id": ["00dc284f-fd96-423b-bb8f-b90ee13439bf"], "package_ndc": ["0378-9651-32", "0378-9651-50"], "is_original_packager": [true], "upc": ["0303789651327"], "nui": ["N0000175454", "M0017805"], "pharm_class_epc": ["Prostaglandin Analog [EPC]"], "pharm_class_cs": ["Prostaglandins [CS]"], "unii": ["WJ68R08KX9"]}, "product_type": "Drugs", "event_id": "89906", "recalling_firm": "Mylan Pharmaceuticals Inc", "address_1": "3711 Collins Ferry Rd", "address_2": "", "postal_code": "26505-2362", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0748-2022", "product_description": "Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-9651-32.", "product_quantity": "20,112 bottles", "reason_for_recall": "Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related substance impurities/degradation during routine stability testing.", "recall_initiation_date": "20220401", "center_classification_date": "20220406", "termination_date": "20230227", "report_date": "20220413", "code_info": "Lot # TV11W101, Exp Mar 2023", "more_code_info": ""}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88091", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in Los Angeles California", "recall_number": "D-0631-2021", "product_description": "Phytonadione Tablets 5 mg, Rx Only, 30 Tablets (3x10) Unit Dose, Manufactured for: AvKARE Pulaski, TN 38478. NDC 50268-661-13", "product_quantity": "10 cartons", "reason_for_recall": "Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.", "recall_initiation_date": "20210609", "center_classification_date": "20210616", "termination_date": "20230602", "report_date": "20210623", "code_info": "Lot: 38617 Exp. 10/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-1022-2016", "product_description": "VANCOMYCIN 50MG/ML OPHTH SOLUTION; packaged in 10mL vial, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 01182016:09@28, Exp. 02/01/2016; Lot #: 03072016:50@49, Exp. 03/21/2016; Lot #: 03232016: 79@7, Exp. 04/06/2016; Lot #:03282016:15@10, Exp. 04/11/2016; Lot #: 04192016:35@14, Exp.07/19/2016."}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0444-2019", "product_description": "Amino Blend Injection, Ornithine/Arginine/Lysine/Lidocaine 75 mg/75 mg/75 mg/10 mg/mL 10 mL, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "158 10 ml vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 08302018@12 BUD: 12/24/2018; 10242018@2 BUD: 2/17/2019"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72699", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0513-2016", "product_description": "Vitamin B-Complex 100, Multi MG Inj, Qty: 30 mL Vial, MFG by: Mylan Institutional, Rockford, IL 61103, Repackaged by: RemedyRepack Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 52125-0873-02", "product_quantity": "1 Vial", "reason_for_recall": "Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.", "recall_initiation_date": "20151111", "center_classification_date": "20151204", "termination_date": "20161101", "report_date": "20151216", "code_info": "Lot # B0105037-100715, Exp 10/01/2016", "more_code_info": ""}, {"status": "Terminated", "city": "San Jose", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75230", "recalling_firm": "Leiter's Compounding", "address_1": "17 Great Oaks Blvd", "address_2": "N/A", "postal_code": "95119-1359", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0010-2017", "product_description": "Atropine Sulfate 0.01% in 0.9% Sodium Chloride (Ophthalmic  Solution) 10 mL Total Volume in a 15 mL Dropper Bottle, Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-011-39", "product_quantity": "76,315 total units, all products", "reason_for_recall": "Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters", "recall_initiation_date": "20160920", "center_classification_date": "20161012", "termination_date": "20170503", "report_date": "20161019", "code_info": "All unexpired lots;  Expirations dates of 11/13/2016 to 01/02/2017"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0224-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 6/PGE-1 60 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "3 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 07142021:43 BUD: 10/23/2021", "more_code_info": ""}, {"country": "United States", "city": "Wichita", "address_1": "8710 E 34th St N", "reason_for_recall": "Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.", "address_2": "", "product_quantity": "840 prefilled syringes", "code_info": "Lot #: C274-000004690, BUD: 09/21/18.", "center_classification_date": "20180706", "distribution_pattern": "Nationwide in the USA", "state": "KS", "product_description": "Neostigmine Methylsulfate Injection Solution, 5 mg per 5 mL, 1 mg per mL, 5 mL prefilled syringe, 5 syringes per package, Rx only, Fagron Sterile Services, ICB Laboratories, 8710 E 34th St. N., Wichita, KS  67205, NDC 71266-2003-02.", "report_date": "20180711", "classification": "Class I", "openfda": {}, "recalling_firm": "Fagron Compounding Services LLC dba Fagron Sterile Services", "recall_number": "D-0910-2018", "initial_firm_notification": "", "product_type": "Drugs", "event_id": "80383", "termination_date": "20200831", "more_code_info": "", "recall_initiation_date": "20180629", "postal_code": "67226-2636", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bedford", "state": "NH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72233", "recalling_firm": "Bedford Pharmacy", "address_1": "209 Route 101", "address_2": "N/A", "postal_code": "03110-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NH, MA", "recall_number": "D-0049-2016", "product_description": "P-P-P  (COBAL) 30-4-40/mL, Injection, Bedford Pharmacy, 209 Route 101, Bedford, NH 03110, (603) 472-3919", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20150922", "center_classification_date": "20151015", "termination_date": "20160608", "report_date": "20151021", "code_info": "Lot #: 09082015@4, Exp 10/23/2015"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0593-2022", "product_description": "Acetaminophen Child Strawberry Oral Suspension (160 mg/5 ml), 4 FL OZ (118 mL) per bottle, MADE WITH PRIDE & CARE FOR H-E-B SAN ANTONIO, TX 78204.  NDC: 37808-759-26", "product_quantity": "3,840 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1GK0905, Exp 01/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Louisville", "state": "CO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86709", "recalling_firm": "Wishgarden Herbs, Incorporated", "address_1": "321 S Taylor Ave Unit 100", "address_2": "N/A", "postal_code": "80027-3600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA, Egypt and Canada.", "recall_number": "D-0218-2021", "product_description": "Happy Ducts Compress, 3 oz. plastic jar, www.wishgardenherbs.com, Boulder, CO. 80301. UPC 6 56490 20223 5", "product_quantity": "46 jars", "reason_for_recall": "Microbial Contamination of a Non-Sterile Product: Product tested positive for Cronobacter Sakazakii.", "recall_initiation_date": "20200925", "center_classification_date": "20210107", "termination_date": "20240529", "report_date": "20210106", "code_info": "Lot # 53664, Exp 08/2022"}, {"status": "Terminated", "city": "Corvallis", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82278", "recalling_firm": "Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy", "address_1": "996 Nw Circle Blvd Ste 105", "address_2": "N/A", "postal_code": "97330-1485", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed in Oregon", "recall_number": "D-1087-2019", "product_description": "DEXAMETHASONE (NAPO4) 0.1% OPHTH* PRES-FREE SOLUTION, 10ml, Eye Drops, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330", "product_quantity": "12 prescriptions", "reason_for_recall": "Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.", "recall_initiation_date": "20190221", "center_classification_date": "20190409", "termination_date": "20200723", "report_date": "20190417", "code_info": "Lots: 23012019@48, 24012019@2, 24012019@36, 28012019@35, 29012019@13, 05022019@5, 11022019@13, 12022019@20, 19022019@1, 19022019@6, 19022019@57, 19022019@61, All lots within expiry distributed between 09-01-2018 to 02-20-2019."}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "380 mL in Vials", "code_info": "Lot #: 160115-3, BUD: 06/11/16;  Lot #: 160202-10, BUD: 06/11/16;  Lot #: 160204-43, BUD: 06/11/16;  Lot #: 160223-3, BUD: 06/11/16;  Lot #: 160307-26, BUD: 06/11/16;  Lot #: 160309-1, BUD: 06/11/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "B-COMPLEX #3 W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 10ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1168-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Little Rock", "address_1": "7321 Cantrell Rd", "reason_for_recall": "Lack of Assurance of Sterility - the firm is recalling select sterile drug products.", "address_2": "", "product_quantity": "48,592 syringes", "code_info": "Lot: 9006 BUD: 1/20/2017, Lot: 8757 BUD: 11/30/2016, Lot: 8954 BUD: 1/6/2017, Lot: 9174 BUD: 2/20/2017", "center_classification_date": "20161213", "distribution_pattern": "Nationwide", "state": "AR", "product_description": "Glycopyrrolate 1 mg/5 mL (0.2 mg/mL) Injection Solution, 5 mL Single-Dose Syringe, For IV Use, Hospital/Office Use Only, Rx Only, Cantrell Drug Co. 7321 Cantrell Rd. Little Rock, AR 72207, NDC 52533-028-15", "report_date": "20161221", "classification": "Class II", "openfda": {}, "recalling_firm": "Cantrell Drug Company", "recall_number": "D-0191-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "75745", "termination_date": "20200429", "more_code_info": "", "recall_initiation_date": "20161118", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91643", "recalling_firm": "Leadiant Biosciences, Inc.", "address_1": "9841 Washingtonian Blvd Ste 500", "address_2": "N/A", "postal_code": "20878-7352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide USA", "recall_number": "D-0327-2023", "product_description": "Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL, 100 mg vial, Rx only, Manufactured by Exelead, Inc., Indianapolis, IN 46268; Distributed by Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 57665-101-41", "product_quantity": "31,879 vials", "reason_for_recall": "Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.", "recall_initiation_date": "20230203", "center_classification_date": "20230215", "termination_date": "20240930", "report_date": "20230222", "code_info": "Lot#: 1203A, Exp. 5/11/2024"}]